Chronic Lymphocytic Leukaemia (CLL)
Management and monitoring of CLL.
Reviewed by Dr Kola Tytler MBBS CertHE MBA MRCGP (General Practitioner)
Last reviewed: 21 October 2025
Clinical Guidelines
CKS: Haematological cancers - recognition and referral
National
ESMO Clinical Practice Guideline: Chronic Lymphocytic LeukaemiaNational
ESMO Clinical Practice Guidelines for chronic lymphocytic leukaemiaNational
Guideline for the treatment of chronic lymphocytic leukaemiaNational
NICE Guidance TA796: Venetoclax for treating chronic lymphocytic leukaemiaNational
NICE Guidance: Venetoclax for treating chronic lymphocytic leukaemiaNational
NICE guideline [NG180]National
Chronic lymphocytic leukaemia Australasian consensus practice statementLocal
Chronic Lymphocytic Leukemia Treatment (PDQ®) - Health Professional VersionLocal
Consensus guidelines for the management of treatment-naïve chronic lymphocytic leukaemia in SingaporeLocal
ESMO Clinical Practice Guideline interim update on new targeted therapies in chronic lymphocytic leukaemiaLocal
ESMO Clinical Practice Guideline: Chronic Lymphocytic LeukaemiaLocal
ESMO Clinical Practice Guidelines: Chronic lymphocytic leukaemiaLocal
Guideline for the treatment of chronic lymphocytic leukaemiaLocal
iwCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLLLocal